NOVEMBER 20245TECH OUTLOOKLAST WORD30Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai LabAccelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsC O NT E NT SCXO INSIGHTSCXO INSIGHTSInsights on CRO Management and Overcoming CMC Challenges inGene TherapyYan Zhi, Director, Cell & Gene Therapy Product Owner, CSL Behring28Risk-based Approach in Vendor Assessment for Clinical Trials (CT) ServicesInguna Adovica, Head of Clinical Research Quality Division, Vadims sis, Head of Medicine & Clinical Research Department, JSC Olainfarm22R&D Lab Automation, a Modern Tool to Accelerate Process DevelopmentStefano Gobbato, R&D Researcher Automation Chemist and Jacopo Roletto, R&D Director, PROCOS S.P.A. (CBC Group)26FEATURED COMPANYTOP 10 TECH OUTLOOKPHARMACOMPANIES IN EUROPE 2024OUTSOURCINGEuroscreenFastDr. Laurent Meeus,Chief Scientist & General Manager18RightSource Revolutionizes Biopharma OutsourcingLuis Berrade, Sr. Director, Global Biologics Testing Sales andIan Wyllie, Director, RightSource Solutions,Charles River Laboratories25
< Page 4 | Page 6 >